Lantis Laser Inc. – OCT Successfully Applied in Many Fields of Medicine
Lantis – StockGuru Profile Lantis – OTC: LSSR.PK
Lantis Laser’s Optical Coherence Tomography (OCT) Dental Imaging System(TM) is superior to anything currently available for dentists.
Lantis Laser has exclusive rights to the OCT technology for dentistry under its license agreements with Lawrence Livermore National Laboratory (LLNL) which is operated by the University of California under contract with the U.S. Department of Energy (DOE), and LightLab Imaging. This new optical technology will allow dentists to non-invasively image the internal structure of soft and hard dental tissue. OCT uses safe, high-intensity light to generate high-resolution cross-sectional images of tissue, without the need for tissue biopsy.
This optical technology has several important advantages over conventional x-ray imaging:
1) a factor of ten higher spatial resolution;
2) the ability to image soft (gums) and hard (enamel and dentin) tissue;
3) safe optical imaging, no ionizing radiation is used; and
4) immediate digital image, no need for film and chemicals.
Potential applications for this technology include:
1) early detection of caries (decay)
2) diagnosis of periodontal disease
3) evaluation of dental restorations
In dentistry, currently used conventional x-ray and the improved digital x-ray have shortcomings in providing meaningful images of dental structures and they are light years away from being able to provide a dentist with the information necessary for early detection. In particular, x-ray cannot image occlusal (biting) surfaces where up to 90% of decay is found.
Optical Coherence Technology has been applied successfully in many fields.
Ophthalmology OCT Applications
Currently being marketed by Carl Zeiss Meditec is an OCT system which is a stand-alone, high-resolution imaging system for the anterior segment of the eye, including the cornea, iris, angle and the lens. OCT has become the gold standard for obtaining high-resolution cross-sectional images of the retina in opthalmology and is now used for anterior segment applications.
OCT application in opthalmology accurately measures corneal thickness to help qualify patients for vision correction surgery. In addition to providing a full-thickness pachymetry map prior to laser surgery, it is the first device to image, measure and document both corneal flap thickness and residual stromal thickness immediately following the procedure — a crucial element in ensuring optimal surgical outcomes.
This month the August edition of the Journal of Cataract & Refractive Surgery published a study in which OCT was found to be a useful noninvasive instrument for diagnosing and monitoring this post-DSEK complication in opthalmology. The study reported a patient with residual Descemet’s membrane was diagnosed by anterior segment optical coherence tomography (AS-Optical Coherence Tomography) after Descemet’s stripping endothelial keratoplasty (DSEK). The Journal notes: “This case report demonstrates that inadequate Descemet’s stripping in the recipient button could be a potential cause of DSEK failure; AS-Optical Coherence Tomography is a useful and noninvasive instrument for diagnosing and monitoring this post-DSEK complication.”
EURYI Awards a Prize in Optical Coherence Tomography
The EURYI in Europe recognized and worked with Optical Coherence Tomography as well. The EURYI is designed to attract outstanding young scientists from around the world to create their own research teams at European research centers and launch potential world-leading research careers. Most awards are between $1,000,000 and $1,250,000, comparable in size to the Nobel Prize.
The average age of this year’s winners is 33.1, making it the youngest group in EURYI’s history. Six of the awardees are women, making it the highest number of female winners in any year.
These young researchers’ works are granted Nobel Prize-scale funding. EURYI has made a huge impact both scientifically and for the European Research Area.
The Biology Department went to structural and functional imaging by Fourier domain in Optical Coherence Tomography with Optical Frequency Comb method and Dr. Maciej Wojtkowski Nicolaus Copernicus University Torun Poland and INSERM Ecole Normale Superieure Paris France.
Cardiology Relies on Optical Coherence Tomography for Imaging
One method capable of identifying vulnerable coronary plaques is optical coherence tomography. The capability of polarization sensitive optical coherence tomography to assess plaque collagen content, in addition to its ability to generate high resolution structural assessments, make it a powerful technology for identifying high-risk plaques.
According to research published in the International Journal of Cardiology, “Current evidence indicates that most plaques classified as vulnerable or ruptured plaque do not lead to unstable angina or myocardial infarction. Improved methods are needed to risk stratify plaques to identify those which lead to most acute coronary syndromes.”
Optical Coherence Tomography has been applied in other fields of medicine with great success. Lantis Laser is next in line to provide this technology to the field of dentistry and they are doing it at a price most dentists can afford.
Lantis Laser provides a crucial tool for oral health!
Source: Lantis Laser Inc., Lawrence Livermore National Laboratory
Contact: Lantis Laser Inc.
Stan Baron,President and CEO
11 Stonebridge Court
Denville, NJ 07834
Tel: (203) 300-7622
Forward-Looking Statements: Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis’ business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statement.
Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.
